Takeda Pharmaceutical Co., Ltd. (TAK)
16.18
+0.02
(+0.15%)
USD |
NYSE |
Jan 20, 12:16
Takeda Pharmaceutical Profit Margin (Quarterly): -1.05% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novartis AG | 28.26% |
| Pfizer Inc. | 21.32% |
| Sanofi | -- |
| Nxera Pharma Co., Ltd. | -24.76% |
| Protagonist Therapeutics, Inc. | -834.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.55% |
| Return on Assets | 0.27% |
| Return on Invested Capital | 0.33% |
| Gross Profit Margin (Quarterly) | 47.41% |
| Operating Margin (Quarterly) | 10.11% |
| Return on Net Operating Assets | 0.30% |